Long-term effect of peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration on peritoneum: A case report

Peritoneal Dialysis International

Volumn 27, Issue 1, 2007, Pages 92-94

  Shimizu, Hideki ^a   Ishibashi, Yoshitaka ^a   Kumagai, Takanori ^a   Kaname, Shinya ^a   Fujita, Toshiro ^a   Sai, Keiko ^b   Nishi, Takahiro ^b   Mise, Naobumi ^b   Tagawa, Hitoshi ^b   Sugimoto, Tokuichiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; ERYTHROPOIETIN; GLUCOSE; ADVANCED GLYCATION END PRODUCT;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CATHETER REMOVAL; DIALYSATE; DRUG MEGADOSE; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MEMBRANE PERMEABILITY; MESOTHELIUM CELL; ORTHOSTATIC HYPERTENSION; PERITONEAL DIALYSIS; PERITONEUM; PH; PRIORITY JOURNAL; VASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DRUG EFFECT; FOLLOW UP; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TIME;

DIALYSIS SOLUTIONS; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROGNOSIS; TIME FACTORS;

EID: 33947120131     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700120     Document Type: Article

References (12)

1. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
2. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005; 25: 248-55.
3. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
4. Lo WK. Dialysis adequacy targets in continuous ambulatory peritoneal dialysis-higher is not necessarily better. Perit Dial Int 2003; 23(Suppl 2):S69-71.
5. Paolo ND, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20(Suppl 3):S5-100.
6. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
7. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
8. Lage C, Pischetsrieder M, Aufricht C, Jorres A, Schilling H, Passlick-Deetjen J. First in vitro and in vivo experiences with stay-safe balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000; 20(Suppl 5):S28-32.
9. Wieczorowska KT, Polubinska A, Schaub TP, Schilling H, Wisniewska J, Witowski J, et al. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Perit Dial Int 2001; 21(Suppl 3): S108-13.
10. Ikehara O, Nishimura H, Naito T, Higuchi C, Sanaka T. Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats. Nephron Exp Nephrol 2005; 100:e30-9.
11. Fusshoeller A, Baehr J, Grabensee B, Plum J. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int 2005; 25:387-93.
12. Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, nutrition, inflammation, atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001; 21(Suppl 3):S157-62.